Is it now time to prepare psychiatry for a psychedelic future?
The British Journal of Psychiatry · 2024
DOI: 10.1192/bjp.2024.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, 2024. Verfasst von David Nutt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychiatry, Imperial College London, UK; and Drug Science, London, UK. Hauptthemen laut MEDLINE: Hallucinogens, Psilocybin, Psychiatry, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Psychiatry, Imperial College London, UK; and Drug Science, London, UK.
- Addiction Psychiatry, Keele University, UK.
- Psychiatry, Kings College London, UK.
ORCID-Profile: David Nutt, Allan H Young
Zitieren
APA
Nutt, D., Crome, I., & Young, A. H. (2024). Is it now time to prepare psychiatry for a psychedelic future?. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2024.76
Vancouver
Nutt D, Crome I, Young AH. Is it now time to prepare psychiatry for a psychedelic future?. The British Journal of Psychiatry. 2024. doi:10.1192/bjp.2024.76
BibTeX
@article{Nutt2024,
author = {Nutt, David and Crome, Ilana and Young, Allan H},
title = {Is it now time to prepare psychiatry for a psychedelic future?},
journal = {The British Journal of Psychiatry},
year = {2024},
doi = {10.1192/bjp.2024.76}
}
EUVIMED